Drug intelligence / Profile preview

sD-NP-GT8 DNA

Development stage
Phase 1
Lead developer
International AIDS Vaccine Initiative
Modality
DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intramuscular
01

Overview

sD-NP-GT8 DNA is a synthetic DNA vaccine candidate designed to encode a germline-targeting HIV immunogen, specifically the GT8 epitope, which is engineered to stimulate broadly neutralizing antibody (bNAb) precursors against HIV. The vaccine utilizes a nanoparticle-based approach, where the GT8 immunogen is scaffolded onto nanoparticles and delivered via plasmid DNA for in vivo expression. This strategy aims to prime B cells capable of maturing into bNAb-producing cells. The vaccine has been evaluated in combination with IL-12 DNA as an adjuvant and may be followed by protein boosts such as trimeric Env proteins (e.g., Trimer 4571). It is being developed primarily for HIV prevention and has been tested in early-phase clinical trials involving healthy adults without HIV[1][2][3][5].

Other names
synthetic DNA-encoded nanoprotein GT8NP-GT8 DNA vaccineNP-GT-8 DNA vaccineNP-GT 8 DNA vaccine

Beyond the preview

Go deeper on sD-NP-GT8 DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sD-NP-GT8 DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call